Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel Life Science Investing
Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101 Genetics Investing
Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE Pharmaceutical Investing
Life Science Big News Roundup: Biocure Signs a Collaboration Agreement with Y Biologics; PreveCeutical Provides Update on the Dual Gene Therapy Program; Lexaria Partners with Altria to Fund Research and Development of DehydraTECH(tm) Technology Life Science Investing
Kura Oncology Reports Clinical Activity of Tipifarnib in Subsets of Pancreatic Cancer Associated with High CXCL12 Expression Life Science Investing
Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz Life Science Investing
TYME’s Novel Metabolic-Based Cancer Therapy, SM-88, Improves Survival in Phase II Study Life Science Investing
Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government Life Science Investing
Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application Pharmaceutical Investing
FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults With Type 1 Diabetes Pharmaceutical Investing
